Bio-Reference Laboratories Inc. Enters Oversold Territory


Bio-Reference Laboratories Inc.’s (BRLI) share price has entered into oversold territory with a stochastic value of 17.5491. The Zacks Consensus Estimate on the company’s earnings for year ending October 2013 increased by a cent over the past two months to $1.76 per share. Bio-Reference Laboratories Inc. is a Zacks Rank #2 (“Buy”) company.


BIO REFERENCE LABS INC NEW (BRLI): Free Stock Analysis Report

Zacks Investment Research

More From
View Comments (0)